The PepR-NIR750 CXCR4 tracer will allow to visualize in vivo the CXCR4 modulating drugs on tumor microenvironment through labeling of CXCR4 positive T and immunoregulatory cells. The gene discussed is CXCR4; the disease is neoplasm.